Radiologically Isolated Syndrome: 5-Year Risk for an Initial Clinical EventDarin T. Okuda, Christine Lebrun‐Frénay, Aksel Sıva et al.|PLoS ONE|2014Cited by 332
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromesEster Cantó, Manuel Comabella, Mar Tintoré et al.|Brain|2015Cited by 191
Genome-Wide Pharmacogenomic Analysis of the Response to Interferon Beta Therapy in Multiple SclerosisEsther Byun, Jorge R. Oksenberg, Stacy J. Caillier et al.|Archives of Neurology|2008Cited by 172
Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibilityNicolas Couturier, David Brassat, Florence Bucciarelli et al.|Brain|2011Cited by 113
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and ProgressionMarianna Cortese, Tuula Pirttilä, Ludwig Kappos et al.|Neurology|2025Cited by 3